{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Sekar A"],"funding":["Urology Foundation","Cancer Research UK","John Fell Fund, University of Oxford","Wellcome Trust","Biotechnology and Biological Sciences Research Council"],"pagination":["e1010815"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10328346"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["19(6)"],"pubmed_abstract":["In prostate cancer, loss of the tumour suppressor gene, Retinoblastoma (Rb), and consequent activation of transcription factor E2F1 typically occurs at a late-stage of tumour progression. It appears to regulate a switch to an androgen-independent form of cancer, castration-resistant prostate cancer (CRPC), which frequently still requires androgen receptor (AR) signalling. We have previously shown that upon mating, binucleate secondary cells (SCs) of the Drosophila melanogaster male accessory gland (AG), which share some similarities with prostate epithelial cells, switch their growth regulation from a steroid-dependent to a steroid-independent form of Ecdysone Receptor (EcR) control. This physiological change induces genome endoreplication and allows SCs to rapidly replenish their secretor"],"journal":["PLoS genetics"],"pubmed_title":["Rbf/E2F1 control growth and endoreplication via steroid-independent Ecdysone Receptor signalling in Drosophila prostate-like secondary cells."],"pmcid":["PMC10328346"],"funding_grant_id":["091911/B/10/Z","BB/N016300/1","C38302/A12278","107457/Z/15/Z","BB/L007096/1","141/063","BB/R004862/1","BB/K017462/1"],"pubmed_authors":["Gandy C","Wilson C","Mendes CC","Leiblich A","Sarma D","Hellberg JEEU","Sekar A","Goberdhan DCI","Hamdy FC","Wainwright SM"],"additional_accession":[]},"is_claimable":false,"name":"Rbf/E2F1 control growth and endoreplication via steroid-independent Ecdysone Receptor signalling in Drosophila prostate-like secondary cells.","description":"In prostate cancer, loss of the tumour suppressor gene, Retinoblastoma (Rb), and consequent activation of transcription factor E2F1 typically occurs at a late-stage of tumour progression. It appears to regulate a switch to an androgen-independent form of cancer, castration-resistant prostate cancer (CRPC), which frequently still requires androgen receptor (AR) signalling. We have previously shown that upon mating, binucleate secondary cells (SCs) of the Drosophila melanogaster male accessory gland (AG), which share some similarities with prostate epithelial cells, switch their growth regulation from a steroid-dependent to a steroid-independent form of Ecdysone Receptor (EcR) control. This physiological change induces genome endoreplication and allows SCs to rapidly replenish their secretor","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Jun","modification":"2025-04-20T03:45:55.251Z","creation":"2025-04-20T03:45:55.251Z"},"accession":"S-EPMC10328346","cross_references":{"pubmed":["37363926"],"doi":["10.1371/journal.pgen.1010815"]}}